Venetoclax demonstrates antitumor activity in relapsed CLL
1. In this phase I trial, gradual dose escalation with selective BCL2 inhibitor, venetoclax, showed a manageable safety profile...
No benefit of continuous over interrupted chest compressions during CPR
1. In this cluster randomization with crossover trial, continuous chest compressions with asynchronous positive pressure ventilation (PPV) during CPR...
Olaparib linked to increased response in metastatic, castration-resistant prostate cancer
1. In this phase II trial, use of the poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitor olaparib showed a positive response in...